AU3332097A - Hybrid herpes virus/epstein-barr virus vector - Google Patents

Hybrid herpes virus/epstein-barr virus vector

Info

Publication number
AU3332097A
AU3332097A AU33320/97A AU3332097A AU3332097A AU 3332097 A AU3332097 A AU 3332097A AU 33320/97 A AU33320/97 A AU 33320/97A AU 3332097 A AU3332097 A AU 3332097A AU 3332097 A AU3332097 A AU 3332097A
Authority
AU
Australia
Prior art keywords
epstein
virus
vector
hybrid herpes
barr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33320/97A
Inventor
Craig A. Strathdee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John P Robarts Research Institute
Original Assignee
John P Robarts Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John P Robarts Research Institute filed Critical John P Robarts Research Institute
Publication of AU3332097A publication Critical patent/AU3332097A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16641—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU33320/97A 1996-07-12 1997-07-11 Hybrid herpes virus/epstein-barr virus vector Abandoned AU3332097A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9614699.8A GB9614699D0 (en) 1996-07-12 1996-07-12 Hybrid herpes virus-based vector for gene delivery and expression
GB9614699 1996-07-12
PCT/CA1997/000487 WO1998002564A1 (en) 1996-07-12 1997-07-11 Hybrid herpes virus/epstein-barr virus vector

Publications (1)

Publication Number Publication Date
AU3332097A true AU3332097A (en) 1998-02-09

Family

ID=10796821

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33320/97A Abandoned AU3332097A (en) 1996-07-12 1997-07-11 Hybrid herpes virus/epstein-barr virus vector

Country Status (3)

Country Link
AU (1) AU3332097A (en)
GB (1) GB9614699D0 (en)
WO (1) WO1998002564A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2793414B1 (en) * 1999-05-10 2003-05-23 Centre Nat Rech Scient NUCLEIC ACID-ANTIBODY CONJUGATE FOR DELIVERING FOREIGN NUCLEIC ACID TO CELLS
CN1117761C (en) * 1999-11-25 2003-08-13 钱其军 Recombination virus able to specifically kill tumor cells associated with EB virus and building process
WO2012089225A1 (en) 2010-12-29 2012-07-05 Curevac Gmbh Combination of vaccination and inhibition of mhc class i restricted antigen presentation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939088A (en) * 1987-02-18 1990-07-03 Meloy Laboratories Inc. Sustained production of recombinant gamma interferon using an Epstein-Barr virus replicon
US5173414A (en) * 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
EP0760861A1 (en) * 1994-05-20 1997-03-12 The Board Of Trustees Of The Leland Stanford Junior University An autonomous replication system for mammalian cells
WO1996029421A1 (en) * 1995-03-23 1996-09-26 Cantab Pharmaceuticals Research Limited Vectors for gene delivery
US5851826A (en) * 1995-07-26 1998-12-22 Children's Medical Center Corporation Helper virus-free herpesvirus vector packaging system
FR2741358B1 (en) * 1995-11-17 1998-01-02 Centre Nat Rech Scient PRODUCTION OF RETROVIRAL VECTORS VIA DNA VIRUS-BASED VIRAL VECTORS

Also Published As

Publication number Publication date
GB9614699D0 (en) 1996-09-04
WO1998002564A1 (en) 1998-01-22

Similar Documents

Publication Publication Date Title
AU2678097A (en) Targeted viral vectors
AU5638496A (en) Viral vectors
AU6021298A (en) Hybrid wavelength-interchanging cross-connect
AU7272696A (en) Hybrid aircraft
GB9415319D0 (en) HSV viral vector
AU2476895A (en) Roadway-powered electric vehicle system
AU6996498A (en) Vehicle handling system
AU7892694A (en) Battery separator
AU6465998A (en) Hybrid fuel-cell electric-combustion power system
AU3081899A (en) Viral vector directed to predetermined target cells
AU681451B2 (en) Batteries having improved venting systems
HUP9904329A3 (en) Herpesvirus saimiri as viral vector
AU1649595A (en) Hybrid vehicle
AU6597298A (en) Battery charging system
AUPO026596A0 (en) Viral peptide
AU2983295A (en) Dual hybrid system
AU5652396A (en) Glucose-inducible recombinant viral vector
AU2377097A (en) Antiviral ricin-like proteins
AU6501399A (en) Mate inferencing system
AUPN861496A0 (en) Lytic peptides
AU3332097A (en) Hybrid herpes virus/epstein-barr virus vector
AUPM278693A0 (en) Road derived energy system
AU2231399A (en) A herpes virus vector
EP0833012B8 (en) Mechanical handling vehicle
AU3251097A (en) Brushless electromagnetic motor-generator